Blue Water Life Science Advisors, LP Care Dx, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $103 Million
- Q2 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 510,000 shares of CDNA stock, worth $11.5 Million. This represents 7.7% of its overall portfolio holdings.
Number of Shares
510,000Holding current value
$11.5 Million% of portfolio
7.7%Shares
8 transactions
Others Institutions Holding CDNA
# of Institutions
164Shares Held
50.8MCall Options Held
60.8KPut Options Held
34.9K-
Black Rock Inc. New York, NY5.29MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$99.2 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.91MShares$88.6 Million1.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$67.7 Million0.89% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.58MShares$58.3 Million0.03% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.21B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...